window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : May 30, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Digital Health

  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Opinion & Events

    Veeva and OpenEvidence form long-term AI partnership to accelerate clinical trial access and drug discovery

    Veeva Systems and OpenEvidence have announced a long-term partnership to [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    OptymEdge appoints senior director to lead global roll-out of ACUVERA platform

    OptymEdge has appointed Amy Del Medico as senior director of [...]

    May 5, 2026
  • Uncategorised

    Prosper AI raises $5M to expand AI-driven healthcare voice platform

    Artificial intelligence is reshaping the pharmaceutical and healthcare industries, accelerating [...]

    October 3, 2025
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Opinion & Events,Pharmaceuticals and therapeutics

    M42 partners with Medical Tourism Association and Mastercard to expand UAE’s global patient reach

    M42, a global health leader leveraging artificial intelligence, technology, and [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Opinion & Events,Therapeutic Areas

    Patient voices take centre stage as Currax leans into authenticity in obesity care

    As debate continues over the cost and sustainability of GLP-1 [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Therapeutic Areas

    Neurogen biomarking virtual care ecosystem cuts time to Alzheimer’s intervention by 4.5 years

    New data presented at the Alzheimer’s Association International Conference 2025 [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Opinion & Events

    Briya launches clinical-grade AI assistant for accelerating medical and epidemiological research

    New AI platform designed to support faster discovery, better study [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Medical devices,Opinion & Events

    Magentiq Eye secures Series A funding to advance AI-powered colonoscopy solutions

    Investment led by aMoon will support US and EU commercialisation [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Opinion & Events

    OMNY Health dataset surpasses 100M patients, creating largest US repository of unstructured clinical data

    OMNY Health has reached a major milestone, announcing that its [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Opinion & Events

    Pharma’s digital reckoning: Why SEO is now a strategic imperative

    With growing debate over a potential ban on DTC TV [...]

    May 5, 2026
Previous234Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Abivax to present nine obefazimod studies at DDW as Phase 3 ulcerative colitis data build
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Opinion & Events, Therapeutic Areas
  • Viz.ai, Johnson & Johnson strike US chronic subdural hematoma AI deal
    Categories: Clinical & Regulatory, Digital & Data, Drug Discovery & Development, Medical devices
  • Veristat acquires Certara regulatory and medical writing business
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Digital & Data, Drug Discovery & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top